Agarwal Sunil's Form 4 filing
Sana Biotechnology, Inc. (SANA) · filed Sep 17, 2021
- Accession no.
- 0001562180-21-005999
- Filed
- Sep 17, 2021
- Trade date
- Sep 15-16, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $1.56M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agarwal SunilCIK 0001616640 | Officer (EVP, Head of Development & CMO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | Common Stock | SSaleDisposed | −58,373 | $26.07 | −$1,521,784.11 | 1,551,627 | Direct | |
| Sep 16, 2021 | Common Stock | SSaleDisposed | −1,627 | $26.00 | −$42,302 | 1,550,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.